<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:18:25Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14463" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14463</identifier><datestamp>2026-10-18T21:14:21Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Serum NT-pro CNP levels in epileptic seizure, psychogenic non-epileptic seizure, and healthy subjects</dc:title><dc:creator>Ceylan, Mustafa</dc:creator><dc:creator>Yalcin, Ahmet</dc:creator><dc:creator>Bayraktutan, Omer Faruk</dc:creator><dc:creator>Laloglu, Esra</dc:creator><dc:subject>Biomarker</dc:subject><dc:subject>Epilepsy</dc:subject><dc:subject>NT-pro CNP</dc:subject><dc:subject>Psychogenic non-epileptic seizure</dc:subject><dc:subject>Adolescent</dc:subject><dc:subject>Adult</dc:subject><dc:subject>Electroencephalography</dc:subject><dc:subject>Female</dc:subject><dc:subject>Healthy Volunteers</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Male</dc:subject><dc:subject>Middle Aged</dc:subject><dc:subject>Natriuretic Peptide, C-Type</dc:subject><dc:subject>Psychophysiologic Disorders</dc:subject><dc:subject>Seizures</dc:subject><dc:subject>Statistics, Nonparametric</dc:subject><dc:subject>Video Recording</dc:subject><dc:subject>Young Adult</dc:subject><dc:subject>biological marker</dc:subject><dc:subject>natriuretic peptide type C</dc:subject><dc:subject>amino terminal sequence</dc:subject><dc:subject>Article</dc:subject><dc:subject>blood brain barrier</dc:subject><dc:subject>brain microcirculation</dc:subject><dc:subject>clinical evaluation</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>excitation</dc:subject><dc:subject>human</dc:subject><dc:subject>major clinical study</dc:subject><dc:subject>neurophysiology</dc:subject><dc:description>Purpose: Epileptic seizure is the result of uncontrollable neural excitation in the brain. The C-type natriuretic peptide is a member of natriuretic peptide hormone family and is synthesized by brain and blood vessels in CNS. NT-pro CNP is an amino-terminal fragment of C-type natriuretic peptide and is more stable compared to its predecessor. In this study, we aimed to evaluate the role of NT-pro CNP in psychogenic non-epileptic seizures, epileptic seizures, and normal subjects. Methods: Thirty-three patients with epilepsy and 43 patients with psychogenic non-epileptic seizures were enrolled in this study. The control group consisted of 28 healthy subjects. Post-ictal serum levels of NT-pro CNP were acquired from all participants. Statistically significant differences between patient groups and controls regarding serum levels of NT-pro CNP were sought. Results: NT-pro CNP levels were significantly lower in the epilepsy group than the psychogenic non-epileptic seizure group and control group with no significant difference between the psychogenic non-epileptic seizure and control group (p &lt; 0.05). Conclusion: Post-ictal serum NT-pro CNP levels were lower in epileptic seizures compared to psychogenic non-epileptic seizures as well as healthy controls. We think that such a difference is associated with C-type natriuretic peptide-related neural mechanisms such as altered microcirculation, increased brain-blood barrier permeability, and synaptic stabilization. © 2018, Springer-Verlag Italia S.r.l., part of Springer Nature.</dc:description><dc:publisher>Springer-Verlag Italia s.r.l.</dc:publisher><dc:date>2018</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14463</dc:identifier><dc:identifier>https://doi.org/10.1007/s10072-018-3562-4</dc:identifier><dc:identifier>1590-1874</dc:identifier><dc:language>en</dc:language><dc:relation>Neurological Sciences</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14463</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>